Compare AdaptHealth Corp (AHCO) vs PepsiCo, Inc. (PEP) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
AdaptHealth Corp vs PepsiCo, Inc. — how do they compare? AdaptHealth Corp trades at $10.1 (market cap $1.38B), while PepsiCo, Inc. trades at $144.13 (market cap $198.15B). The key difference: PepsiCo, Inc. is far larger — about 143.6× AdaptHealth Corp's market cap, and PepsiCo, Inc. pays a 4.08% dividend while AdaptHealth Corp pays none. Which is the better fit depends on your goals.
| AHCO | PEP | |
|---|---|---|
Market Cap | $1.38B | $198.15B |
Sector | Health | Consumer Staples |
52-Week High | $13.38 | $170.44 |
52-Week Low | $8.68 | $133.81 |
Enterprise Value | $3.33B | $240.05B |
Dividend Yield | — | 4.08% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
AdaptHealth (AHCO) trades at $10.27, down 4.55% today, with neutral technical signals and mixed fundamental performance. The company reported Q1 2026 earnings miss with negative EPS of -$0.06 versus $0.0125 expected, continuing a pattern of recent quarterly misses. Despite revenue growth to $3.3B projected for 2026, net income remains negative with -2.43% margin. Analyst consensus remains bullish with 75% buy ratings and $14.80 price target, representing 44% upside potential from current levels.
The investment case balances strong analyst support and reasonable valuation (P/S 0.42, EV/EBITDA 7.17) against persistent profitability challenges. Recent refinancing improves financial flexibility, but execution on cost controls and margin improvement remains critical. The stock offers significant upside if management can translate revenue growth into sustainable profitability, though current negative earnings trend presents near-term headwinds.
PepsiCo (PEP) trades at $143.51, showing minimal daily movement with a 0.15% gain. The stock maintains a bullish technical signal despite bearish moving averages, supported by strong fundamentals including consistent earnings beats and robust profitability metrics. Recent news highlights price adjustments in snack products and institutional accumulation, while the company prepares for Q1 2026 earnings with expectations of in-line results and ongoing North American recovery focus.
PepsiCo presents a stable investment case with strong cash flow generation and dividend reliability, though margin pressures and competitive pricing dynamics pose near-term risks. Analyst consensus leans bullish with a $161.73 price target, suggesting 13% upside potential from current levels, supported by institutional confidence and strategic business optimization initiatives.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About AdaptHealth Corp
AdaptHealth provides patient-centered healthcare-at-home solutions in the U.S. It offers medical equipment and supplies for sleep therapy, respiratory health, diabetes management, and general home wellness.
Read more on AHCO →About PepsiCo, Inc.
PepsiCo is one of the largest food and beverage companies globally. It makes, markets, and sells a slew of brands across the beverage and snack categories, including Pepsi, Mountain Dew, Gatorade, Doritos, Lays, and Ruffles. The firm uses a largely integrated go-to-market model, though it does leverage third-party bottlers, contract manufacturers, and distributors in certain markets. In addition to company-owned trademarks, Pepsi manufactures and distributes other brands through partnerships and joint ventures with companies such as Starbucks. The firm segments its operations into five primary geographies, with North America (comprising Frito-Lay North America, Quaker Foods North America, and North America beverages) constituting around 60% of consolidated revenue.
Read more on PEP →
